Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
Abstract Background Somatostatin receptor 68Ga PET imaging is standard for evaluation of a patient’s suitability for 177Lu peptide receptor radionuclide therapy of neuroendocrine tumours (NETs). The 68Ga PET serves to ensure sufficient somatostatin receptor expression, commonly evaluated qualitative...
Main Authors: | Anna Stenvall, Johan Gustafsson, Erik Larsson, Daniel Roth, Anna Sundlöv, Lena Jönsson, Cecilia Hindorf, Tomas Ohlsson, Katarina Sjögreen Gleisner |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-12-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13550-022-00947-2 |
Similar Items
-
Predictive power of the post-treatment scans after the initial or first two courses of [177Lu]-DOTA-TATE
by: Alexandre Chicheportiche, et al.
Published: (2018-12-01) -
Case report: 177Lu DOTA-TATE: a new scheme for the treatment of prostate neuroendocrine cancer
by: Xin-yuan Yu, et al.
Published: (2023-12-01) -
Combination of [<sup>177</sup>Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model
by: Marina Simón, et al.
Published: (2022-06-01) -
Preliminary assessment of <sub>225</sub>Ac excretion in patients undergoing radionuclide therapy with <sub>225</sub>Ac-DOTA-TATE
by: L. A. Chipiga, et al.
Published: (2023-10-01) -
Replacing Lu-177 with Tb-161 in DOTA-TATE and PSMA-617 therapy: potential dosimetric implications for activity selection
by: Frederik A. Verburg, et al.
Published: (2023-11-01)